Search results
Results from the WOW.Com Content Network
Stratafix knotless tissue devices [22] Surgicel absorbable hemostats [23] Monarch platform [24] [25] [26] Breast augmentation and reconstruction MemoryGel Breast Implants [27] MemoryShape Breast Implants [28] [29] Artoura Breast Tissue Expanders [30] CPX Breast Tissue Expenders [31] Mentor Saline Breast Implants [32] Eye health (Johnson ...
This page was last edited on 10 October 2024, at 13:53 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. [ 3 ] Based in Sydney , Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered ...
The FDA granted 510(k) clearance for ClearPoint Neuro Inc's (NASDAQ: CLPT) version 2.1 of the ClearPoint Neuro Navigation software. Version 2.1 of the ClearPoint System is intended to provide ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Meril Life Sciences is an Indian multinational medical device company, with headquarters in Vapi, Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group. [2] The company is engaged in the manufacturing of vascular intervention devices, orthopedic implants, endosurgery, ENT products and in-vitro diagnostics. Meril Life ...
It claims that more than half of GP practices across the UK use EMIS Health software and holds number one or two market positions in its main markets. [2] In June 2022 the company was acquired by Bordeaux UK Holdings II Limited, an affiliate of UnitedHealth 's Optum business for a 49% premium on EMIS's closing share price.
A medical device is an instrument, apparatus, implant, in vitro reagent, or similar or related article that is used to diagnose, prevent, or treat disease or other conditions, and does not achieve its purposes through chemical action within or on the body (which would make it a drug).